CASI Pharmaceuticals (NASDAQ:CASI) reported its Q1 earnings results on Wednesday, May 17, 2023 at 07:35 AM.
Here's what investors need to know about the announcement.
Earnings
CASI Pharmaceuticals beat estimated earnings by 29.69%, reporting an EPS of $-0.45 versus an estimate of $-0.64.
Revenue was down $715 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $1.07 which was followed by a 3.83% increase in the share price the next day.
Here's a look at CASI Pharmaceuticals's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.37 | -0.46 | -0.64 | -0.9 |
| EPS Actual | -1.44 | -0.38 | -0.56 | -0.6 |
| Revenue Estimate | 10.79M | 9.90M | 7.87M | 9.23M |
| Revenue Actual | 15.26M | 10.21M | 8.57M | 9.06M |
To track all earnings releases for CASI Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
